MariMed Q1 revenue $39.5M (+4.2% YoY); net loss narrows to $3.8M; adj. EBITDA $3.6M

MARIMED INC.

Revenue $39.5M, up 4.2% YoY from $37.9M.
GAAP net loss $3.8M, improved from $5.5M loss in prior year.
Non-GAAP net loss $3.2M, improved from $3.9M.
Adjusted EBITDA $3.6M (9% margin) vs $2.5M (7% margin) YoY.
Gross margin slightly declined: GAAP 39% (vs 40%), Non-GAAP 40% (vs 41%).

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.75

MARIMED INC. reported financial results for first quarter ended March 31, 2026.

Period: first quarter ended March 31, 2026
Result: reported results

Exact text from the filing

On May 13, 2026, MariMed Inc. (the “Company”) issued a press release, a copy of which is attached hereto as Exhibit 99.1 and is incorporated herein by reference, announcing its financial results for the three-month period ended March 31, 2026.

View on SEC.gov

Browse all earnings releases →

MARIMED INC. filing history →

Source: SEC EDGAR

accession 0001522767-26-000070

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.